Female sexual dysfunction in androgenetic alopecia: Case-control study
July 2016
in “Canadian Urological Association journal”
TLDR Hair loss in women linked to higher sexual dysfunction risk.
This case-control study from 2016 investigated the relationship between female sexual dysfunction (FSD) and androgenetic alopecia (AGA) in premenopausal women. The study found that FSD was more prevalent in patients with AGA compared to those without AGA, and that age, AGA, metabolic syndrome, and free testosterone were independent risk factors for FSD. The study suggests that further investigation is needed to understand the role of hormones, ischemia, inflammation, and psychosocial situation on the development of FSD in patients with MetS and/or AGA. The study provides important insights into the relationship between FSD and AGA in premenopausal women.
View this study on cuaj.ca →
Cited in this study
research Female pattern alopecia: current perspectives
Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.
research New investigational drugs for androgenetic alopecia
Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.
research Improvement in scalp hair growth in androgen‐deficient women treated with testosterone: a questionnaire study
Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.
research The association of insulin resistance and metabolic syndrome in early androgenetic alopecia.
People with early hair loss may have higher insulin levels and a greater chance of developing metabolic syndrome.
research Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey
Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.
research Testosterone therapy for sexual dysfunction in postmenopausal women
Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.
research Hair Loss, Insulin Resistance, and Heredity in Middle-aged Women. a Population-based Study
Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.
research Androgen Replacement in Women: A Commentary
Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.
research Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex
Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.